Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea

Journal of the American College of Cardiology

Volumn 39, Issue 2, 2002, Pages 202-209

  Morrison, L Katherine ^a   Harrison, Alex ^a   Krishnaswamy, Padma ^a   Kazanegra, Radmila ^a   Clopton, Paul ^a   Maisel, Alan ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; COR PULMONALE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DYSPNEA; HEART LEFT VENTRICLE PRESSURE; HUMAN; LUNG CANCER; LUNG DISEASE; LUNG EMBOLISM; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SECRETION; VALIDATION PROCESS;

EID: 0037116539     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01744-2     Document Type: Article

References (32)

1. Discriminating causes of dyspnea through the clinical examination
2. The diagnostic usefulness of history of the patient with dyspnea
3. BNP: Pathophysiological and potential therapeutic roles in acute congestive heart failure
4. Biochemistry of natriuretic peptides
5. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators
6. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
7. Brain natriuretic peptide predicts mortality in the elderly
8. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
9. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population
10. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
11. Clinical criteria and biochemical markers for the detection of systolic dysfunction
12. Utility of b-type natriuretic peptide (BNP) in the diagnosis of CHF in an urgent care setting
13. Effects of prehospital medications on mortality and length of stay in CHF
14. The limited availability of physical signs for estimating hemodynamics in chronic heart failure
15. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction
16. Recommendations concerning use of echocardiography in hypertension and general population research
17. Prospects for using a blood sample in the diagnosis of heart failure
18. Natriuretic peptides - Relevance in cardiac disease
19. Plasma brain natriuretic peptide in assessment of acute dyspnea
20. Neurohumoral measurements as indicators of long term prognosis after acute myocardial infarction
21. Utility, of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction
22. A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure
23. A rapid test for B-type natriuretic peptide (BNP) correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study
24. Dyspnea differentiation index, a new method for the rapid separation of cardiac versus pulmonary dyspnea
25. Can quantitative capnometry differentiate between cardiac and obstructive causes of respiratory distress
26. Utility of peak expiratory flow rate in the differentiation of acute dyspnea
27. Assessment of lung auscultation by paramedics
28. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension
29. Increased brain natriuretic peptide and atrial peptide plasma concentration in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure